ADIPOQ rs1501299: What Your Genotype Means
The rs1501299 variant is a single-nucleotide polymorphism located within the ADIPOQ gene, which encodes the protein adiponectin. Research suggests this variant may influence how an individual's body regulates insulin sensitivity and metabolic responses to dietary intake.
What each genotype means
Lower breast cancer risk
Research suggests that individuals with this genotype may have a slightly lower risk of breast cancer compared to those with the C/C genotype. This variant is also studied for its role in adiponectin signaling, which influences how your body regulates insulin and inflammation.
This is the less common genotype for this variant in many populations.
Intermediate risk profile
Carriers of this genotype show an intermediate profile in studies regarding breast cancer risk and adiponectin signaling. Because this gene is involved in metabolic regulation, your specific response to dietary changes regarding insulin sensitivity may differ from those with other genotypes.
This heterozygous genotype is found at moderate frequencies across various global populations.
Common metabolic variant
This is the most common genotype for this variant. Some studies have associated this genotype with a higher risk of breast cancer compared to the A allele, and it may influence how your body responds to dietary interventions regarding insulin resistance and adiponectin levels.
This is the most frequently observed genotype in most studied populations.
Understanding the rs1501299 Variant
The rs1501299 variant is a common genetic change found within the ADIPOQ gene, situated on chromosome 3. In genetic literature, it is sometimes referred to as a +276G>T polymorphism. This variant is located in an intronic region, meaning it does not directly alter the sequence of the protein produced by the gene, but it may influence how the gene is expressed or regulated. Because it is a single-nucleotide polymorphism (SNP), it involves a change at a specific position in the DNA sequence where one nucleotide is replaced by another. Scientists study these variations to understand how subtle differences in our genetic code contribute to the diversity of human metabolic traits and health outcomes across different populations.
The Role of the ADIPOQ Gene
The ADIPOQ gene provides instructions for making a protein called adiponectin. This protein is primarily secreted by adipose (fat) tissue and circulates in the bloodstream, where it plays a critical role in metabolic and hormonal processes. Adiponectin is known for its involvement in regulating glucose levels and fatty acid breakdown, which are essential for maintaining insulin sensitivity. By influencing these pathways, adiponectin helps the body manage energy balance and inflammation. Because of its central role in metabolism, variations in the ADIPOQ gene are frequently investigated in studies related to metabolic syndrome, type 2 diabetes, and other conditions where insulin regulation is a key factor. Understanding how this gene functions provides a foundation for exploring how specific variants like rs1501299 might impact overall metabolic health.
Research Associations and Evidence
Scientific research has explored the association between rs1501299 and various metabolic markers, including insulin resistance and adiponectin levels. Some studies have indicated that individuals with different genotypes at this position may show varying responses to dietary interventions, such as hypocaloric diets, regarding improvements in their lipid profiles and insulin sensitivity. Additionally, the variant has been examined in the context of cancer risk and inflammatory markers, though the strength of evidence varies across different studies and populations. It is important to note that these findings are statistical associations observed in research cohorts rather than direct causes of disease. The evidence for rs1501299 is considered moderate, as results can be influenced by environmental factors, diet, and the complex interplay with other genetic variants. Consequently, these associations should be viewed as part of a broader, ongoing effort to map the genetic architecture of human metabolism.
Population Frequency
The frequency of the rs1501299 variant is variable and depends significantly on ancestral background. Genetic databases indicate that both the G and T alleles are present in human populations, though their distribution is not uniform globally. Because population frequency can influence the statistical power of genetic studies, researchers often account for ancestry when analyzing the impact of this variant. There is no single 'normal' frequency, as the prevalence of specific genotypes shifts across different geographic and ethnic groups. This variability highlights the importance of considering diverse populations in genomic research to ensure that findings are robust and applicable to a wide range of individuals.
Interpreting Your Genetic Information
Genetic information regarding variants like rs1501299 is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions without professional input. While research suggests potential links between this variant and metabolic traits, these associations are complex and influenced by many factors, including lifestyle, diet, and other genes. You cannot determine your health status or risk for specific conditions based solely on this SNP. If you are interested in how your genetics might relate to your metabolic health or if you are considering dietary changes, it is essential to discuss this information with a qualified healthcare provider or a registered dietitian. They can help you interpret your results in the context of your overall health history and provide personalized guidance that is safe and evidence-based.
How common is this variant?
The rs1501299 variant shows variable frequency across different global populations, with the G and T alleles appearing at different rates depending on ancestral background.
Frequently asked questions
Can rs1501299 predict if I will develop diabetes?
No, this variant cannot predict the development of diabetes. While it is studied in the context of metabolic health, diabetes is a complex condition influenced by many genetic, environmental, and lifestyle factors.
Should I change my diet based on my rs1501299 genotype?
You should not make significant dietary changes based solely on this genetic variant. Always consult with a healthcare professional or a registered dietitian before making changes to your diet to ensure they are appropriate for your specific health needs.
Is rs1501299 the same as other ADIPOQ variants?
No, rs1501299 is a specific SNP within the ADIPOQ gene. Other variants in the same gene may have different functions or associations, and they are often studied independently or in combination.
Where can I find more information about my specific genotype?
You can discuss your genetic reports with a genetic counselor or your primary care physician. They can help you understand the limitations of current research and how it applies to your personal health context.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1501299?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Common regulatory promoter polymorphism in the adiponectin gene associated with circulating adiponectin levels and insulin sensitivity.
This variant in the adiponectin gene is associated with improved insulin sensitivity and reduced susceptibility to obesity phenotypes.
Common promoter variation (-11391G>A) in the adiponectin gene associated with circulating adiponectin levels and risk of insulin resistance.
This SNP in the adiponectin gene is associated with insulin sensitivity and metabolic syndrome risk.
This SNP is studied for its role in adiponectin levels and metabolic response to diet.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.